United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 29300-169_06c83876-99c5-4ed1-8727-1a0d93452020
- Product NDC
- 29300-169
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- Unichem Pharmaceuticals (USA), Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130401
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 300 TABLET in 1 BOTTLE, PLASTIC (29300-169-03) · 29300-169-03
- 500 TABLET in 1 BOTTLE, PLASTIC (29300-169-05) · 29300-169-05
- 1000 TABLET in 1 BOTTLE, PLASTIC (29300-169-10) · 29300-169-10
- 150 TABLET in 1 BOTTLE, PLASTIC (29300-169-15) · 29300-169-15
- 90 TABLET in 1 BOTTLE, PLASTIC (29300-169-19) · 29300-169-19
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →